Pharmacogenomics and patient stratification at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

16 organizations at FoG London 2027 present work in pharmacogenomics & patient stratification: 9 NHS, government and non-profit bodies, 4 universities and research institutes and 3 suppliers and service providers. Between them they bring 56 presentations to the program. Most represented: UCL, University of Cambridge and Queen Mary University of London. As of Oct 29, 2026.

All 243 organizations at FoG London 2027 →

Format
Top represented
Showing 1–6 of 16 organizations
OrganizationFoG London 2027 Attendance
UCL
London, UK
Universities & institutes
Multidisciplinary London research university with faculties of medical, life, brain and population health sciences, including the Great Ormond Street Institute of Child Health.
Talk
Wed Jan 27
11:30–12:00
What Do We Need to Get More Advanced Therapies to Patients?
How regulatory changes in the US, UK and EU, plus practical rollout models, could bring more advanced therapies to patients.
Talk
Wed Jan 27
12:30–13:00
Quantitative Proteomics to Unravel Signaling in Rare Cells
How mapping protein phosphorylation in just hundreds of cells reveals dormant, drug-resistant glioblastoma cells and leftover disease in acute myeloid leukaemia.
Talk
Wed Jan 27
14:30–15:00
Resolving RNA Diversity in Neurodegenerative Disease: From Mechanism to Therapeutic Targeting
How large human brain RNA datasets link disease-associated genetic variants to genes and mechanisms in Lewy body disorders and related neurodegenerative diseases.
Talk
Wed Jan 27
15:30–16:00
Tracing Metastatic Evolution with Spatial Biology: Insights for Immunity and Immune Evasion
How mapping cells in place across primary tumours and their metastases reveals the earliest steps of cancer spread and immune escape.
Talk
Wed Jan 27
15:30–16:00
Why Does the Food Environment Affect Us Differently?
What it means to call obesity genetic, how genes and food surroundings interact to shape weight, and what a twin study shows.
Population & social genomics
Talk
Wed Jan 27
16:30–17:00
Personalised Surveillance in Ovarian Cancer: Does It Work?
Whether tracking a blood tumour marker over time helps women at high genetic risk of ovarian cancer who are awaiting preventive surgery.
Talk
Wed Jan 27
16:30–17:00
Why Do We Age So DIfferently?
Why people with similar genes and lifestyles age at different rates, and what genetically identical organisms reveal about chance in ageing.
Population & social genomics
Talk
Thu Jan 28
10:30–11:00
Who Do We Think We Are? What the Last Decade of Genomics Has Revealed About Us
What ancient DNA has revealed about human migration and ancestry, and what genetics can and cannot say about race and identity.
Population & social genomics
Talk
Thu Jan 28
11:30–12:00
Ageing as a Modifiable Process: From Lifestyle to Therapeutic Intervention
How exercise, sleep, diet and social life shape ageing, and whether existing drugs could target ageing biology to delay disease.
Talk
Thu Jan 28
11:30–12:00
Beyond Screening: The Next Generation of Prenatal Genomics
Women & Children's Health Stage
Talk
Thu Jan 28
12:30–13:00
Rewriting the Rules: Gene Therapy and Clinical Trials in Pregnancy
Why pregnant women were long excluded from clinical trials, how pregnancy research can now run safely, and what fetal gene therapy could offer.
Panel
Thu Jan 28
14:40–15:10
What Will Human Evolution Look Like Next?
Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next.
with Francis Crick Institute, University of Cambridge, Anglia Ruskin University
Population & social genomics
Talk
Thu Jan 28
16:10–16:40
25 Years of Gene Therapy for Inherited Immune Disorders: Progress and Future Potential
How gene and cell therapies are moving from experiments toward potential cures for inherited blood diseases and cancer, and what blocks wider access.
Talk
Thu Jan 28
16:10–16:40
Critical Appraisal of Polygenic Risk Scores and Circulating Proteins for Screening, Risk Stratification and Individual Risk Prediction
How to judge whether polygenic risk scores and blood protein markers really help with screening, risk grouping and predicting individual disease risk.
Talk
Thu Jan 28
16:40–17:10
From Research to Reality: Ensuring Women Benefit from Innovation
How to design women's health tests and technologies that work for all women, and who risks being left behind by them.
with University Hospital Southampton NHS Foundation Trust, St George's University Hospitals NHS Foundation Trust
Universities & institutes
Collegiate research university in Cambridge, England, whose School of Clinical Medicine sits on the Cambridge Biomedical Campus beside Addenbrooke's Hospital.
Talk
Wed Jan 27
11:30–12:00
Integrating Spatial Multi-Omics: From Technology Development to Biological Discovery
How combining RNA and protein maps of tissue shows how ovarian tumour cells interact with immune cells across body sites and tumour types.
Talk
Wed Jan 27
11:30–12:00
Preeclampsia and Fetal Growth Restriction: From Prediction to Prevention
How tracking proteins, RNA and metabolites through pregnancy could flag placental problems like preeclampsia and fetal growth restriction before symptoms appear.
Talk
Wed Jan 27
15:30–16:00
Tracking the Emergence and Spread of Antimicrobial Resistance Through Bacterial Genomics
How building family trees from bacterial genomes dates the rise of drug-resistant strains, measures policy effects and traces hospital outbreaks.
Talk
Wed Jan 27
16:30–17:00
Beyond Single-Gene Testing: Using Polygenic Risk to Guide Precision Treatment
How a person's overall genetic profile, not single genes, could show who benefits most from diabetes and high blood pressure treatments.
Talk
Wed Jan 27
17:30–18:00
From Stem Cell States to Stem Cell Flux: Navigating Cellular Landscapes Using scRNA Seq
How single-cell RNA sequencing and computer models reconstruct the paths stem cells take as they change and choose their fates.
Talk
Wed Jan 27
17:30–18:00
Using AI and Spatial Multiomics to Decode Tumour Evolution and Identify High-Risk Cancer
Why cancers with similar genetic drivers behave so differently, and how AI applied to maps of tumour tissue could flag aggressive cancers earlier.
Talk
Thu Jan 28
08:45–09:15
Why Are We Hungry? What Genomics Is Revealing About Appetite and Obesity
What rare genetic cases, population studies and cell-by-cell brain maps reveal about the biology of appetite and obesity.
Single-cell genomicsPopulation & social genomics
Panel
Thu Jan 28
14:10–14:40
Is Modern Life Fighting Our Human Biology?
Whether modern food environments and inactive lifestyles clash with our evolved biology, and why genetics makes some people more prone to obesity.
with University of Oxford, University of Leeds, Leeds Beckett University
Population & social genomics
Panel
Thu Jan 28
14:40–15:10
What Will Human Evolution Look Like Next?
Evidence that humans are still evolving, and how disease, climate, migration and gene editing could shape where evolution goes next.
with Francis Crick Institute, Anglia Ruskin University, UCL
Population & social genomics
Talk
Thu Jan 28
15:10–15:40
Beyond Polygenic Risk Scores: Integrating Genetics and Multi-Omic Data for Personalised Risk Stratification and Earlier Screening
How large international collaborations are improving cardiovascular risk prediction, and the evidence tying overweight and obesity to higher death rates.
Talk
Thu Jan 28
16:40–17:10
Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA
How a method that reads very scarce tumour DNA in the blood tracks lung cancer's evolving cell populations and hints at hidden immunotherapy resistance.
Universities & institutes
London research university with genomic medicine, computational biology, clinical pharmacology and population health research.
Talk
Wed Jan 27
11:30–12:00
AI Agents for Rare Disease Diagnosis: Accelerating Variant Interpretation in Clinical Genomics
How AI agents and large language models can speed up interpreting genetic variants for rare disease diagnosis within NHS genomic services.
Talk
Wed Jan 27
11:30–12:00
Pharmacogenomics in Healthcare
How health systems could adopt pharmacogenomics, testing genes to guide prescribing, and whether to test in advance or only when needed.
Talk
Wed Jan 27
11:30–12:00
Proteomics to Identify Disease-Associated Variants in Patients with Rare Disease Undiagnosed After Genome Sequencing
How unusually low blood protein levels could help diagnose rare disease patients left undiagnosed after whole-genome sequencing, and flag new disease genes.
Talk
Wed Jan 27
11:30–13:00
Interactive Session: Building Trust in AI – Identifying Bias, Data Leakage and Hidden Failure Modes
Genome Dome · with University of Edinburgh, University of Surrey, The Alan Turing Institute +2 more
AI in drug discovery & diagnostics
Talk
Wed Jan 27
15:30–16:00
Telomere Biology Disorders: Insights into Early-Life Programming and Lifelong Disease Risk
How rare congenital disorders show why telomeres, the protective caps on chromosome ends, matter early in life and shape lifelong disease risk.
Talk
Thu Jan 28
14:10–14:40
From Genomic Risk to Precision Prevention: Transforming Women's Cancer Care
How population genomic testing can find people at higher risk of women's cancers and guide targeted screening and prevention.
Talk
Thu Jan 28
15:10–15:40
A Human DNA Methylation Atlas for Epigenomic Interpretation
How an atlas of DNA methylation marks across healthy human cell types helps interpret epigenetic data and cell-free DNA in blood.
Talk
Thu Jan 28
16:40–17:10
Rethinking Monogenic DIsease in the Era of Population Genomics
How population-scale genome data and new ways to detect repeated DNA sequences are changing how single-gene diseases are understood.
Government & non-profit
UK health research programme recruiting millions of adult volunteers who share health data and blood samples to study prevention and early detection.
Booth
Exhibiting at Booth 106B
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Genomics England, UK Biobank, NIHR BioResource +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Genomics England, UK Biobank, NIHR BioResource
Talk
Wed Jan 27
14:30–15:00
From Risk Prediction to Precision Prevention
How large population cohorts let researchers study disease risk before symptoms appear, to find biomarkers and build evidence for prevention.
Talk
Wed Jan 27
14:30–16:00
Trust in the Data Age: Who Should Access Our Genomic Data and Why?
Genome Dome · with NIHR BioResource
Biodata & bioinformaticsPopulation & social genomics
Talk
Thu Jan 28
12:00–12:30
Finding The Right Participants For The Right Research
How matching people by clinical, genetic or risk profile to suitable studies could speed recruitment for precision clinical research.
Government & non-profit
Government-owned company providing whole-genome sequencing for the NHS Genomic Medicine Service and research, including the Generation newborn study.
Panel
Wed Jan 27
10:20–11:00
The UK's Health Data Advantage: Powering the Future of Life Sciences
What makes the UK's national genomic and health datasets valuable, and where they and AI could advance disease research and drug discovery.
with Our Future Health, UK Biobank, NIHR BioResource +1 more
Biodata & bioinformatics
Talk
Wed Jan 27
14:30–15:00
Building the UK’s Health Data Ecosystem: What’s Next for Our National Genomic & Population Resources?
Plans for the UK's major genomic and health data resources, and how to link them while protecting privacy and public trust.
with Our Future Health, UK Biobank, NIHR BioResource
Talk
Wed Jan 27
14:30–15:00
The Generation Study: Insights From a National Study of Newborn Genome Sequencing
What a national study sequencing newborn genomes has learned so far about recruitment and results, and what it means for newborn screening.
Talk
Thu Jan 28
14:40–15:10
The Genomics England Adult Population Programme
How Genomics England is designing a genomics programme for the adult population, what public engagement has taught, and its future plans.
NHS & hospitals
NHS trust running St George's Hospital in Tooting, a south-west London teaching hospital with clinical genetics services.
Talk
Wed Jan 27
15:30–16:00
Beyond the Diagnostic Odyssey: What Comes After Genomic Diagnosis?
How whole-genome sequencing is diagnosing children with rare developmental disorders, and what it takes to move from diagnosis to targeted treatment.
Talk
Wed Jan 27
17:30–18:00
Genotype-Guided Antiplatelet Therapy in Acute Ischemic Stroke
Why some stroke patients resist the anti-clotting drug clopidogrel, and the evidence for and barriers to genetic testing that guides treatment.
Talk
Thu Jan 28
14:10–15:40
Behind the Result, Beyond the Report: Collaborative Case Discussions on Genomic Testing Dilemmas from Different Perspectives
Genome Dome · with Oxford University Hospitals NHS Foundation Trust
Genomic medicine & rare disease
Talk
Thu Jan 28
16:40–17:10
From Research to Reality: Ensuring Women Benefit from Innovation
How to design women's health tests and technologies that work for all women, and who risks being left behind by them.
with University Hospital Southampton NHS Foundation Trust, UCL

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in pharmacogenomics & patient stratification

Tell us what you sell and we’ll find the people at organizations working on pharmacogenomics & patient stratification most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse FoG London 2027 by

Exhibit hall

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction